Probiotics for Diaper Dermatitis
ConditionDiaper Dermatitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-2
SponsorUniversity Maribor
About this trial
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is:
Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years?
Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups.
Participants will:
* receive 6 droplets daily of probiotic or placebo for 3 weeks and * observe and record improvement of diaper rash symptoms each day using a diary.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
presence of diaper dermatitis
age less than two years
Disqualifiers
previous use of probiotics
age more than two years
an acute bacterial infection
chronic disease
Trial design
Design model
Parallel
Treatments tested in this trial
OMNiBiOTiC® Panda
Dietary supplementMultistrain Probiotic OMNiBiOTiC® Panda containing: Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Bifidobacterium lactis W52 Lactococcus lactis W58 and sunflower oil
Placebo
Other interventionPlacebo containing sunflower oil and maltodextrin
Treatment groups
42 Participants
are divided into 2 treatment groupsGroup A: PROBIOTICExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Duration of diaper dermatis
Comparison of the duration of diaper dermatitis in children younger than two years in both arms via daily the use of the diary.
Time frame
3 weeks supplementationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov